Batori, R.K.; Bordan, Z.; Padgett, C.A.; Huo, Y.; Chen, F.; Atawia, R.T.; Lucas, R.; Ushio-Fukai, M.; Fukai, T.; Belin de Chantemele, E.J.;
et al. PFKFB3 Connects Glycolytic Metabolism with Endothelial Dysfunction in Human and Rodent Obesity. Antioxidants 2025, 14, 172.
https://doi.org/10.3390/antiox14020172
AMA Style
Batori RK, Bordan Z, Padgett CA, Huo Y, Chen F, Atawia RT, Lucas R, Ushio-Fukai M, Fukai T, Belin de Chantemele EJ,
et al. PFKFB3 Connects Glycolytic Metabolism with Endothelial Dysfunction in Human and Rodent Obesity. Antioxidants. 2025; 14(2):172.
https://doi.org/10.3390/antiox14020172
Chicago/Turabian Style
Batori, Robert K., Zsuzsanna Bordan, Caleb A. Padgett, Yuqing Huo, Feng Chen, Reem T. Atawia, Rudolf Lucas, Masuko Ushio-Fukai, Tohru Fukai, Eric J. Belin de Chantemele,
and et al. 2025. "PFKFB3 Connects Glycolytic Metabolism with Endothelial Dysfunction in Human and Rodent Obesity" Antioxidants 14, no. 2: 172.
https://doi.org/10.3390/antiox14020172
APA Style
Batori, R. K., Bordan, Z., Padgett, C. A., Huo, Y., Chen, F., Atawia, R. T., Lucas, R., Ushio-Fukai, M., Fukai, T., Belin de Chantemele, E. J., Stepp, D. W., & Fulton, D. J. R.
(2025). PFKFB3 Connects Glycolytic Metabolism with Endothelial Dysfunction in Human and Rodent Obesity. Antioxidants, 14(2), 172.
https://doi.org/10.3390/antiox14020172
